Yao DF - Search Results

1

Carnitine palmitoyltransferase-II inactivity promotes malignant progression of metabolic dysfunction-associated fatty liver disease via liver cancer stem cell activation.

Wang LL, Lu YM, Wang YH, Wang YF, Fang RF, Sai WL, Yao DF, Yao M. Wang LL, et al. Among authors: yao df. World J Gastroenterol. 2024 Dec 21;30(47):5055-5069. doi: 10.3748/wjg.v30.i47.5055. World J Gastroenterol. 2024. PMID: 39713165 Free PMC article.

2

Early monitoring values of oncogenic signalling molecules for hepatocellular carcinoma.

Yao M, Fang RF, Xie Q, Xu M, Sai WL, Yao DF. Yao M, et al. Among authors: yao df. World J Gastrointest Oncol. 2024 Jun 15;16(6):2350-2361. doi: 10.4251/wjgo.v16.i6.2350. World J Gastrointest Oncol. 2024. PMID: 38994143 Free PMC article.

3

[Overexpression of tuftelin and KLF-5 and its clinicopathological features in hepatitis B virus-related hepatocellular carcinoma].

Yang JL, Fang RF, Xie Q, Tai BJ, Yao DF, Yao M. Yang JL, et al. Among authors: yao df. Zhonghua Gan Zang Bing Za Zhi. 2024 Feb 20;32(2):148-154. doi: 10.3760/cma.j.cn501113-20231107-00174. Zhonghua Gan Zang Bing Za Zhi. 2024. PMID: 38514264 Chinese.

4

The Rate of Infusion Represents an Important Aspect of Administering Anticancer Agents.

Lan MJ, Yao DF, Zhu LL, Zhou Q. Lan MJ, et al. Among authors: yao df. Risk Manag Healthc Policy. 2023 Nov 22;16:2531-2541. doi: 10.2147/RMHP.S442692. eCollection 2023. Risk Manag Healthc Policy. 2023. PMID: 38024501 Free PMC article. Review.

5

[Prevalence rate and risk factor analysis of nonalcoholic fatty liver disease in 115 female patients with schizophrenia].

Yu Y, Zhao J, Jin YL, Xie Q, Yao DF, Yao M. Yu Y, et al. Among authors: yao df. Zhonghua Gan Zang Bing Za Zhi. 2023 Sep 20;31(9):947-953. doi: 10.3760/cma.j.cn501113-20230407-00148. Zhonghua Gan Zang Bing Za Zhi. 2023. PMID: 37872090 Chinese.

6

Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis.

Yao M, Zhou P, Qin YY, Wang L, Yao DF. Yao M, et al. Among authors: yao df. World J Gastroenterol. 2023 Mar 28;29(12):1765-1778. doi: 10.3748/wjg.v29.i12.1765. World J Gastroenterol. 2023. PMID: 37032731 Free PMC article. Review.

7

Dephosphorylation of T517 on Hemocyanin Is Required for Antibacterial Activity in Penaeus vannamei.

Feng Q, Aweya JJ, Huang YQ, Zhang P, Wang F, Yao DF, Zheng ZH, Li EM, Zhang YL. Feng Q, et al. Among authors: yao df. J Immunol. 2023 May 1;210(9):1396-1407. doi: 10.4049/jimmunol.2200598. J Immunol. 2023. PMID: 36971684

8

Human PARP1 substrates and regulators of its catalytic activity: An updated overview.

Zhu T, Zheng JY, Huang LL, Wang YH, Yao DF, Dai HB. Zhu T, et al. Among authors: yao df. Front Pharmacol. 2023 Feb 23;14:1137151. doi: 10.3389/fphar.2023.1137151. eCollection 2023. Front Pharmacol. 2023. PMID: 36909172 Free PMC article. Review.

9

[Regulatory mechanism and potential value of circular RNA in nonalcoholic fatty liver disease progression].

Xie Q, Wang LL, Wang L, Yao DF, Yao M. Xie Q, et al. Among authors: yao df. Zhonghua Gan Zang Bing Za Zhi. 2022 Nov 20;30(11):1270-1275. doi: 10.3760/cma.j.cn501113-20220827-00444. Zhonghua Gan Zang Bing Za Zhi. 2022. PMID: 36891710 Review. Chinese.

10

Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis.

Yao M, Wang JJ, Chen XY, Sai WL, Yang J, Wang DF, Wang L, Yao DF. Yao M, et al. Among authors: yao df. Hepatobiliary Pancreat Dis Int. 2023 Jun;22(3):263-269. doi: 10.1016/j.hbpd.2022.11.004. Epub 2022 Nov 11. Hepatobiliary Pancreat Dis Int. 2023. PMID: 36435702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters